Metformin for Prevention of Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1345/APH.1D537PMID 15150378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin sensitizers.

  2003cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes

  2001cited by this paper
• Rethinking the diabetes prevention program clinical trial.

  1999cited by this paper
• Insulin sensitizers.

  1997cited by this paper
• The Effect of Metformin on the Metabolic Abnormalities Associated With Upper-Body Fat Distribution. BIGPRO Study Group

  1996cited by this paper

• BDE-47 Disrupts Gut Microbiota and Exacerbates Prediabetic Conditions in Mice: Therapeutic Potential of Grape Exosomes and Antioxidants

  2025cites this paper
• Mitigating Ibrutinib‐Induced Ventricular Arrhythmia and Cardiac Dysfunction With Metformin

  2024cites this paper
• Analysis of Methylglyoxal Concentration in a Group of Patients with Newly Diagnosed Prediabetes

  2023cites this paper
• Efficacy and Safety of Teneligliptin as Add on Therapy in Indian Type 2 Diabetes Mellitus T2DM Patients Having Dyslipidemia

  2020cites this paper
• Influence of Plantago ovata husk (dietary fiber) on the bioavailability and other pharmacokinetic parameters of metformin in diabetic rabbits

  2017cites this paper
• The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome

  2012cites this paper
• Understanding the Genetic Basis for Adverse Drug Effects: The Calcineurin Inhibitors

  2010cites this paper
• GENETIC BASIS FOR ADVERSE DRUG EFFECTS Bai et al Calcineurin Inhibitor – Induced Nephrotoxicity Mechanism

  2010cites this paper
• METFORMINA, FUNCION ARTERIAL Y GROSOR INTIMA-MEDIA EN SUJETOS CON SINDROME METABOLICO

  2009cites this paper
• The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta‐analysis

  2009cites this paper
• METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY

  2008cites this paper
• Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.

  2006cites this paper
• Question 2 : What do we know about the pathophysiology of prediabetes ?

  2005cites this paper
• Pre-diabetes essential action: a European perspective.

  2005cites this paper
• Nutrient Interactions and Glucose Homeostasis

  2005cites this paper